Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...

"The risk of diabetic ketoacidosis linked to continuous subcutaneous insulin infusion in type 1 diabetes has significantly ...

Tandem Diabetes Care has responded to an FDA recall notice that the organization calls its "most serious" after hundreds of ...

Insulin infusion sets without pumps were also tested under a separate pressure protocol to simulate rapid decompression. This ...

An insulin pump can more closely mimic the way a healthy pancreas works, through a Continuous Subcutaneous Insulin Infusion (CSII), replaces the need for frequent injections by delivering precise ...

For instance, chemotherapy for cancer patients requires precise and controlled drug delivery, which infusion pumps facilitate. Similarly, patients with diabetes often need insulin infusion pumps ...

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for ... traditional insulin pumps, pump supplies, and pharmaceuticals.